Search

for
Search:

GlossaryGolimumab

medication that inhibits TNF-alpha to treat autoimmune diseases

Golimumab is a medication used to treat autoimmune conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in inflammation and immune system responses. This helps reduce symptoms and prevent joint damage in affected individuals.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 36 results

research First Two Cases of Alopecia Areata During Golimumab Therapy

1 citations, October 2015 in “Joint bone spine”

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

research Interventions for Nail Psoriasis

65 citations, January 2013 in “Cochrane library”

Some systemic treatments work for nail psoriasis but can have serious side effects.

research Repigmentation of Hair Following Adalimumab Therapy

17 citations, January 2015 in “Dermatology online journal”

A patient's grey hair regained color during treatment with adalimumab.

research Pityriasis Amiantacea: A Unique Presentation of Psoriasis Associated With Tumour Necrosis Factor-Alpha Inhibitor Therapy

1 citations, September 2023 in “Rheumatology advances in practice”

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

research Adverse Effects and Drug Interactions of Biologic Agents

March 2010 in “Anti-inflammatory & anti-allergy agents in medicinal chemistry”

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

View more "golimumab" in research →

Community Join

0 / 0 results

— no results